Amgen (AMGN) Times Interest Earned (2009 - 2026)

Amgen (AMGN) recorded quarterly Times Interest Earned of $4.06 in Q1 2026, down 2.58% quarter-over-quarter from $4.17 in Q4 2025, and up 149.05% on a YoY basis from $1.63 in Q1 2025.

Amgen (AMGN) Times Interest Earned (2009 - 2026) Analysis & Trends

Amgen's Times Interest Earned history runs 18 years deep, the most recent figure standing at $4.06 for Q1 2026.

  • In Q1 2026, Times Interest Earned rose 149.05% year-over-year to $4.06; the TTM figure through Mar 2026 stood at $3.93 (up 61.22% YoY), while the FY2025 annual figure was $3.3, up 43.27% from the prior year.
  • Times Interest Earned was $4.06 for Q1 2026 at Amgen, down from $4.17 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $8.47 in Q1 2022 to a low of $1.2 in Q1 2024.
  • Historically, Times Interest Earned has averaged $3.86 across 5 years, with a median of $3.57 in 2023.
  • The sharpest annual moves came in 2023 and 2026: Times Interest Earned plunged 71.19% in 2023, then soared 149.05% in 2026.
  • A 5-year view of Times Interest Earned shows it stood at $5.37 in 2022, then slumped by 71.19% to $1.55 in 2023, then jumped by 99.84% to $3.09 in 2024, then surged by 34.64% to $4.17 in 2025, then retreated by 2.58% to $4.06 in 2026.
  • The last three Times Interest Earned figures came in at $4.06 (Q1 2026), $4.17 (Q4 2025), and $3.69 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -13.73
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 23.39
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 4.06
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 10.78
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.06
Dec 31, 2025 4.17
Sep 30, 2025 3.69
Jun 30, 2025 3.83
Mar 31, 2025 1.63
Dec 31, 2024 3.09
Sep 30, 2024 2.64
Jun 30, 2024 2.36
Mar 31, 2024 1.20
Dec 31, 2023 1.55
Sep 30, 2023 2.66
Jun 30, 2023 3.57
Mar 31, 2023 3.54
Dec 31, 2022 5.37
Sep 30, 2022 7.23
Jun 30, 2022 6.63
Mar 31, 2022 8.47
Dec 31, 2021 6.88
Sep 30, 2021 8.03
Jun 30, 2021 2.95